Skip to main content
Fig. 2 | Cancer Cell International

Fig. 2

From: ITC-6102RO, a novel B7-H3 antibody-drug conjugate, exhibits potent therapeutic effects against B7-H3 expressing solid tumors

Fig. 2

B7-H3 expression in lung and breast cancer. (A) B7-H3 mRNA levels in lung and breast cancer patient cohorts from the TCGA database. (B) Western blotting of B7-H3 expression in tumor and normal tissues of lung and breast cancer patients. Equal loading of protein samples was verified using anti-β-actin. (C) Patients in lung and breast cancer cohorts were divided into groups with relatively high or low B7-H3 expression for the Kaplan-Meier plot

Back to article page

Cancer Cell International

ISSN: 1475-2867

Contact us